Yazdan Yazdanpanah, MD, MSc, PhD

Director of the ANRS Emerging Infectious Diseases Agency, Head, Infectious Disease Department, Bichat Claude Bernard Hospital and Professor of Medicine, Paris Diderot University

Dr. Yazdanpanah is the Director of the ANRS Emerging Infectious Diseases Agency, the Director of the Infectious Disease Department at Bichat Claude Bernard Hospital and a Professor of Medicine at Paris Diderot University.

Dr. Yazdanpanah earned his medical degree from the Lille School of Medicine, France in 1996. He qualified from the same institution first as a hepato-gastroenterologist in 1996 and then as an infectious disease specialist in 2002. He earned a Master of Science degree in epidemiology from the Harvard T.H. Chan School of Public Health in 2000 and a PhD degree in Public Health from the Bordeaux School of Public Health in 2002. In 2006, he became a Professor of Infectious Disease.

Research interests include the clinical epidemiology of HIV and viral hepatitis, and the pharmaco-economics of antimicrobial agents. He is one of the coordinators of Inserm “REACTing” a network under the umbrella of Aviesan (REsearch and ACTion targeting emerging infectious disease), the goal of which is to optimize and coordinate the existing research capacities during emerging and re-emerging infection threats.  In February 2017, Dr. Yazdanpanah was appointed as the Director of the French Aviesan Institute of Immunology, Inflammation, Infectiology, and Microbiology and the Chair of the Global Research Collaboration for Infectious Disease Preparedness International Network. Dr. Yazdanpanah has published extensively in peer-reviewed journals and makes frequent presentations at numerous national and international meetings.

“The Program in Clinical Effectiveness that I followed in 1998 and 1999 at Harvard School of Public Health had an important impact on my career. It guided my first steps in clinical research and provided a strong basis for research I conducted during my career. It also allowed me to meet clinicians from the US but also other parts of the world with whom I collaborated after the end of the program.”